Human MIP synthase splice variants in bipolar disorder

Alon Shamir, Galit Shaltiel, Shirly Mark, Yuly Bersudsky, Robert H. Belmaker, Galila Agam

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


Objectives: Alternative splicing allows the production of multiple gene products with different functions from a given sequence, affecting cellular function control. Tissue-specific splicing is most prevalent in the brain. We therefore investigate whether splice variants contribute to complex psychiatric disorders. A database search suggested that the myo-inositol-1-phosphate (MIP) synthase gene, possibly involved in pathophysiology of bipolar disorder, has splice variants. Methods: Human RNA was purified from lymphocytes and postmortem brain. MIP synthase alternative splice variants were amplified using reverse transcription-polymerase chain reaction. Results: The bioinformatics finding was confirmed in both tissues. No difference in lymphocyte MIP synthase mRNA splice-variant levels was found between bipolar patients and controls. However, patients with family history of a major psychiatric disorder had significantly higher levels of the variant lacking exons 3 and 4 versus patients with no family history and controls. Conclusions: As alternative splicing may be a mechanism by which the ∼30,000 genes are amplified in mammalian brain, further studies with other candidate genes for psychiatric disorders are needed.

Original languageEnglish
Pages (from-to)766-771
Number of pages6
JournalBipolar Disorders
Issue number7
StatePublished - 1 Nov 2007


  • Alternative splicing
  • Bipolar disorder
  • Gene expression
  • Inositol
  • Mood stabilizers
  • Myo -inositol-1-phosphate synthase

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry


Dive into the research topics of 'Human MIP synthase splice variants in bipolar disorder'. Together they form a unique fingerprint.

Cite this